Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Settlement topic
No spam. Unsubscribe anytime.
Dalton opts into two opioid settlement agreements; city to receive unknown allocation
Summary
The council authorized participation in settlement agreements with Purdue Pharma and the Sackler family and with eight opioid manufacturers; staff said the city’s share will depend on statewide opt-in totals and funds will support local recovery services.
Dalton — The Dalton City Council voted July 21 to authorize the city to participate in two recent national opioid settlement agreements: one with Purdue Pharma and the Sackler family (Resolution 25-13) and another with eight opioid manufacturers (Resolution 25-14).
Andrew Parker, city administrator, said the city had previously joined three national opioid settlements since 2023 and that the Georgia Attorney General’s office coordinated acceptance of new settlements. Parker said the city does not yet know the dollar amount Dalton will receive because the allocation depends on how many Georgia cities and counties opt in. He said the city has previously used opioid settlement funds to support local recovery and treatment services.
Both resolutions authorized the city administrator and the chief financial officer to execute documents needed to opt in.
Why it matters: These settlements are a continuing source of local funding for addiction treatment and recovery services. While the precise allocation to Dalton is not yet known, staff emphasized the funds will be directed to mitigate opioid abuse locally.
What happens next: The administrator and CFO will execute opt-in documents; staff will notify local service providers once allocation amounts are determined.
